Nektar Therapeutics (NKTR) Financial Statements (2024 and earlier)

Company Profile

Business Address 455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO, CA 94158
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments504,977733,9551,061,8961,324,8621,335,350296,132
Cash and cash equivalents88,22725,218198,95596,363194,9054,762
Short-term investments416,750708,737862,9411,228,4991,140,445291,370
Receivables5,98122,49238,88936,80243,2135,014
Inventory, net of allowances, customer advances and progress billings19,20215,80115,29212,66511,38110,726
Inventory19,20215,80115,29212,66511,38110,726
Other current assets15,80823,33318,02015,38721,29314,948
Other undisclosed current assets   3,90831,83426,450 
Total current assets:545,968795,5811,138,0051,421,5501,437,687326,820
Noncurrent Assets
Operating lease, right-of-use asset53,435117,025126,476 
Property, plant and equipment32,45160,51059,66264,99948,85147,463
Long-term investments and receivables 64,828136,662279,119582,88957,088
Long-term investments 64,828136,662279,119582,88957,088
Intangible assets, net (including goodwill) 76,50176,50176,50176,50176,50176,501
Goodwill 76,50176,50176,50176,50176,50176,501
Other noncurrent assets2,2452,7441,4611,0104,244994
Other undisclosed noncurrent assets    134,177  
Total noncurrent assets:164,632321,608400,762555,806712,485182,046
TOTAL ASSETS:710,6001,117,1891,538,7671,977,3562,150,172508,866
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities37,27540,95046,25646,31329,07627,307
Interest and dividends payable  4,1984,1984,198
Employee-related liabilities15,73514,53211,4679,9378,263
Accounts payable12,9809,74722,13919,2345,8544,782
Accrued liabilities24,29515,4689,58511,4149,08710,064
Deferred revenue   91 
Debt    248,693  
Other liabilities    924493446
Deferred revenue and credits18,949
Contract with customer, liability5,51713,892
Other undisclosed current liabilities30,92944,25069,43252,44638,5419,461
Total current liabilities:68,20485,200115,779353,89382,00256,163
Noncurrent Liabilities
Long-term debt and lease obligation  125,736136,373 246,950245,207
Long-term debt, excluding current maturities     246,950245,207
Liabilities, other than long-term debt120,38031,3188,9803,32230,03431,013
Deferred revenue and credits25,021
Deferred revenue   2,464 
Contract with customer, liability2,55410,744
Deferred rent credit     9,300
Other liabilities7,5513,5926,5167689,9905,992
Operating lease, liability112,829125,736136,373 
Derivative instruments and hedges, liabilities  27,726    
Other undisclosed noncurrent liabilities155,378195,427200,340214,75073,61188,655
Total noncurrent liabilities:275,758352,481345,693218,072350,595364,875
Total liabilities:343,962437,681461,472571,965432,597421,038
Equity
Equity, attributable to parent366,638679,5081,077,2951,405,3911,717,57587,828
Common stock191918171715
Additional paid in capital3,574,7193,516,6413,388,7303,271,0973,147,9252,207,865
Accumulated other comprehensive income (loss)(6,907)(4,157)(2,295)(1,005)(6,316)(2,111)
Accumulated deficit(3,201,193)(2,832,995)(2,309,158)(1,864,718)(1,424,051)(2,117,941)
Total equity:366,638679,5081,077,2951,405,3911,717,57587,828
TOTAL LIABILITIES AND EQUITY:710,6001,117,1891,538,7671,977,3562,150,172508,866

Income Statement (P&L) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues92,055101,907152,915114,6171,193,323307,711
Revenue, net66,215
Cost of revenue(157,565)(24,897)(50,484)(21,374)(24,412)(46,528)
Cost of goods and services sold(21,635)(24,897)(19,477)(21,374)(24,412)(30,547)
Gross profit:(65,510)77,010102,43193,2431,168,911261,183
Operating expenses(310,656)(523,113)(527,542)(533,278)(480,979)(320,825)
Operating income (loss):(376,166)(446,103)(425,111)(440,035)687,932(59,642)
Nonoperating income (expense)11,183(77,177)(18,836)(19)(5,207)(36,434)
Investment income, nonoperating      
Other nonoperating income (expense)6,6672,56918,28246,33537,5714,520
Interest and debt expense   (6,851)(21,310)(21,582)(22,085)
Income (loss) from continuing operations before equity method investments, income taxes:(364,983)(523,280)(450,798)(461,364)661,143(118,161)
Other undisclosed income from continuing operations before income taxes   6,85121,31021,58222,085
Income (loss) from continuing operations before income taxes:(364,983)(523,280)(443,947)(440,054)682,725(96,076)
Income tax expense (benefit)(3,215)(557)(493)(613)(1,412)(616)
Income (loss) from continuing operations:(368,198)(523,837)(444,440)(440,667)681,313(96,692)
Income (loss) before gain (loss) on sale of properties:(523,837)(444,440)(440,667)681,313(96,692)
Net income (loss) available to common stockholders, diluted:(368,198)(523,837)(444,440)(440,667)681,313(96,692)

Comprehensive Income ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(368,198)(523,837)(444,440)(440,667)681,313(96,692)
Other comprehensive income (loss)(2,750)(1,862)(1,290)5,311(4,205)252
Comprehensive income (loss), net of tax, attributable to parent:(370,948)(525,699)(445,730)(435,356)677,108(96,440)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: